By Professor Gail Matthews

Book Chapters

Martinello M; Hajarizadeh B; Grebely J; Matthews G; Dore G, 2019, 'Cure and Control: What Will It Take to Eliminate HCV?', in Sofia M (ed.), HCV: The Journey from Discovery to a Cure: Volume II, Springer International Publishing, pp. 447 - 490, http://dx.doi.org/10.1007/7355_2018_56

Price V, 2014, 'HIV, viral hepatitis and STIs: a guide for primary care', in Burke M; Matthews G; Dore G; Cowie B (ed.), , Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine, Sydney, https://www.ashm.org.au/products/product/1976963411

Matthews G; Martinello MK; van Beek I; Burns M, 2014, 'Exposure and acute viral hepatitis', in HIV, Viral Hepatitis and STIs: A Guide for Primary Care

Matthews G; Dore GJ, 2009, 'HIV and hepatitis C co-infection', in Dore G; Temple-Smith M; Lloyd A (ed.), Hepatitis C: An Expanding Perspective, IP Communications, East Hawthorn, pp. 308 - 329

Journal articles

Sábato S; Benet S; Rogers AJ; Murray TA; Skeans M; Mothe B; Paredes R; Mourad A; Kiweewa F; Kamel D; Jain MK; Lutaakome J; Nalubega MG; Sebudde N; Mylonakis E; Braun DL; Hatlen T; Kimuli I; Kitko C; Mugerwa H; Kitonsa J; Kim K; Tien PC; Highbarger J; McCormack AL; Sanchez A; Murray DD; Babiker AG; Davey VJ; Files DC; Gelijns AC; Higgs ES; Kan VL; Matthews GV; Pett SL; Lane HC; Reilly C; Goodman AL; Lundgren JD; Moltó J; Yeo HP; Diong SH; Ong SWX; Chia PY; Young BE; Uche B; Idoko G; Habib Z; Kwaghe V; Eriobu N; Amodeo A; de Lara CT; Grüttner-Durmaz M; West E; Günthard HF; Martí R; Martínez L; Pena AMM; Morales-Rull JL; Borras B; Otero S; Martínez X; del Amo E; Campins M; Ausín C; Gomez J; Padure S; Di Natale M; Fernández-Cruz E; Muñoz J; Roldan M; Legarda A; Balerdi L; Trilla A; Sabato S; Abad E; Martínez A; Badillo J; Expósito M; Theresa N; Mugerwa O; Okoth I; Nabankema E; Kisuule R; Wangi D; Nalaaki M; Lubega G; Kibirige M; Nabaggala P; Nandhego J; Naluyinda H; Tukamwesiga N; Atukunda A; Segawa I; Mbabazi Q; Kirenga B; Nantongo C; Alum PI; Nyiraguhirwa D, 2025, 'SARS-Cov-2 vaccination strategies in hospitalized recovered COVID-19 patients: a randomized clinical trial (VATICO Trial)', Scientific Reports, 15, http://dx.doi.org/10.1038/s41598-025-92742-x

Tillakeratne S; Valerio H; Alavi M; Hajarizadeh B; Martinello M; Petoumenos K; George J; Amin J; Matthews GV; Grebely J; Pearson SA; Dore GJ, 2025, 'Corrigendum to “Missed opportunities in HCV care: Trends in late diagnosis and treatment” (JHEP Reports (2025) 7(9), (S2589555925001521), (10.1016/j.jhepr.2025.101474))', Jhep Reports, 7, http://dx.doi.org/10.1016/j.jhepr.2025.101561

Khanna S; Wilson D; Virk S; Bhat A; Houston L; Matthews G; Nerlekar N; Arnott C, 2025, 'Evaluation of the Clinical Significance of Carotid Plaque Characteristics in Ischaemic Stroke: A Systematic Review and Meta-Analysis', Heart Lung and Circulation, 34, pp. 1041 - 1049, http://dx.doi.org/10.1016/j.hlc.2025.08.015

Masters J; Goodman-Meza D; Russell D; Marks L; McCreary E; Jacka B; Seear K; Davis JS; Matthews G; Martinello M; Tong SYC; Dore GJ, 2025, 'Bacterial and fungal infections in persons who inject drugs', Clinical Microbiology Reviews, 38, pp. e0016223, http://dx.doi.org/10.1128/cmr.00162-23

Dharan NJ; Sharma S; Arenas-Pinto A; Duprez D; Estrada V; Ha K; Angelica Kundro M; Mngqibisa R; Mugerwa H; Munroe D; Nasreddine R; Peterson TE; Sereti I; Trevillyan JM; Baker JV; Matthews GV; Phillips AN, 2025, 'Early versus deferred antiretroviral therapy initiation and long-term cardiovascular disease outcomes in people with HIV: The START study', Open Forum Infectious Diseases, 12, http://dx.doi.org/10.1093/ofid/ofaf561

Tillakeratne S; Valerio H; Alavi M; Hajarizadeh B; Martinello M; Petoumenos K; George J; Amin J; Matthews GV; Grebely J; Pearson SA; Dore GJ, 2025, 'Missed opportunities in HCV care: Trends in late diagnosis and treatment', Jhep Reports, 7, http://dx.doi.org/10.1016/j.jhepr.2025.101474

Ang J; Hajarizadeh B; Tillakeratne S; Dore GJ; Treloar C; Amin J; van Dyk J; Degenhardt L; Applegate T; Dunlop A; Fraser C; Conway B; Wong A; Fuchs D; Powis J; Mason K; Gane EJ; Weltman M; Read P; Martinello M; Rowe E; Baker DA; Wade A; Matthews G; Lafferty L; Lloyd A; Grebely J; Cunningham EB, 2025, 'Reinfection following successful direct-acting antiviral therapy for hepatitis C virus infection among people with recent injecting drug use: the SHARP-C study', International Journal of Drug Policy, 143, http://dx.doi.org/10.1016/j.drugpo.2025.104859

Nyein PP; Borok M; Eriobu N; Kaplan R; Kumarasamy N; Avihingsanon A; Losso MH; Azwa I; Karyana M; Dao S; Cisse M; Villanueva JFA; Lupo S; Cardoso SW; Yunihastuti E; Subronto YW; Fitriah M; Katu S; Brown D; Papot E; Hutchinson J; Kelleher A; Hanson J; Dharan NJ; Petoumenos K; Matthews G, 2025, 'A Randomized Trial to Compare Dolutegravir Plus Boosted Darunavir Versus Recommended Standard of Care Antiretroviral Regimens in People With HIV-1, Whose First-line Non-nucleoside Reverse Transcriptase Inhibitor Therapy Has Failed: Final 96-week Results of the D²EFT Study', CLINICAL INFECTIOUS DISEASES, http://dx.doi.org/10.1093/cid/ciaf346

Jensen TO; Sharma S; Avihingsanon A; Lutaakome J; Brar I; Burman W; Chetchotisakd P; de Castro N; Galán-Herrera JF; Kumarasamy N; Paredes R; Ridzon R; Sciaudone M; Singh K; Uriel A; Lundgren J; Reilly C; Matthews G, 2025, 'Risk of severe bacterial infections including TB before and after immediate or deferred antiretroviral therapy: A multicenter, prospective, cohort study', International Journal of Infectious Diseases, 156, http://dx.doi.org/10.1016/j.ijid.2025.107911

Young J; Wang S; Sacks-Davis R; Stewart A; Van Santen DK; Van Der Valk M; Doyle JS; Matthews G; Berenguer J; Wittkop L; Lacombe K; Rauch A; Stoové M; Hellard M; Klein MB, 2025, 'Liver Fibrosis Regression in People Living With HIV After Successful Treatment for Hepatitis C', Journal of Acquired Immune Deficiency Syndromes 1999, 99, pp. 166 - 174, http://dx.doi.org/10.1097/QAI.0000000000003646

Goodman-Meza D; Weiss RE; Poimboeuf ML; Feng J; Vijayan T; Martinello M; Matthews GV; Dore GJ, 2025, 'Comparative Effectiveness of Long-Acting Lipoglycopeptides vs Standard-of-Care Antibiotics in Serious Bacterial Infections', JAMA Network Open, 8, http://dx.doi.org/10.1001/jamanetworkopen.2025.11641

Masters J; Jacka B; Barault M; Goodman-Meza D; Russell D; Matthews GV; Dore GJ; Valerio H; Martinello M, 2025, 'Incidence, Patient-Directed Discharge, Readmission, and Mortality Among People Hospitalized With Injecting-Related Infection: A Population-Based Linkage Study', Open Forum Infectious Diseases, 12, http://dx.doi.org/10.1093/ofid/ofaf257

Jacka BP; Cheng QL; Schiavone B; Darley DR; Kelleher AD; Dore GJ; Matthews GV, 2025, 'Trajectories of Health-Related Quality of Life 2 Years After Mild/Moderate Severe Acute Respiratory Syndrome Coronavirus 2 Infection in the Pre-Omicron Era', Open Forum Infectious Diseases, 12, http://dx.doi.org/10.1093/ofid/ofaf142

Tillakeratne S; Valerio H; Alavi M; Hajarizadeh B; Martinello M; George J; Matthews G; Grebely J; Pearson SA; Dore GJ, 2025, 'Trends in cause-specific mortality among people with hepatitis C virus in New South Wales, Australia', International Journal of Drug Policy, 139, http://dx.doi.org/10.1016/j.drugpo.2025.104790

Nyein PP; Petoumenos K; Dharan NJ; Hanson J; Matthews GV, 2025, 'Reply to Dr Martinez: Refining Our Understanding of the Association between Integrase Inhibitor Therapy and Elevations in Blood Pressure', Clinical Infectious Diseases, 80, pp. 927, http://dx.doi.org/10.1093/cid/ciae345

Wheeler A; Masters J; Pradhan A; Roth JM; Degenhardt L; Dore GJ; Matthews GV; Cunningham EB; Peacock A; Colledge-Frisby S; Grebely J; Hajarizadeh B; Martinello M, 2025, 'Prevalence of Injection-Related Bacterial and Fungal Infection Among People Who Inject Drugs: A Systematic Review and Meta-analysis', Open Forum Infectious Diseases, 12, http://dx.doi.org/10.1093/ofid/ofaf108

Reilly C; Mylonakis E; Dewar R; Young B; Nordwall J; Bhagani S; Chia PY; Davis R; Files C; Ginde AA; Hatlen T; Helleberg M; Hayanga A; Jensen TO; Jain MK; Kalomenidis I; Kim K; Lallemand P; Lindegaard B; Menon A; Ognenovska K; Poulakou G; Thorup Røge B; Rogers AJ; Shaw-Saliba K; Sandkovsky U; Trautner BW; Vasudeva SS; Vekstein A; Viens K; Wyncoll J; DuChateau B; Zhang Z; Wu S; Babiker AG; Davey V; Gelijns A; Higgs E; Kan V; Lundgren J; Matthews GV; Lane HC, 2025, 'Evaluation of the Feasibility and Efficacy of Point-of-Care Antibody Tests for Biomarker-Guided Management of Coronavirus Disease 2019', Journal of Infectious Diseases, 231, pp. 677 - 683, http://dx.doi.org/10.1093/infdis/jiae452

Papot E; Tovar-Sanchez T; Woods J; Thaurignac G; Eriobu N; Borok M; Kaplan R; Avihingsanon A; Azwa I; Grinsztejng B; Kumarasamy N; Sokhela S; Mpoudi-Etame M; Arriaga M; Jacoby S; Matthews GV; Losso MH; Khoo S; Calmy A; Kouanfack C; Ayouba A; Petoumenos K; Venter WDF; Delaporte E; Polizzotto MN, 2025, 'SARS-CoV-2 cross-sectional serosurvey across three HIV-1 therapeutic clinical trials in Africa', AIDS, 39, pp. 448 - 456, http://dx.doi.org/10.1097/QAD.0000000000004068

Young C; Singh M; Jackson KJL; Field MA; Peters TJ; Angioletti-Uberti S; Frenkel D; Ravishankar S; Gupta M; Wang JJ; Agapiou D; Faulks ML; Al-Eryani G; Luciani F; Gordon TP; Reed JH; Danta M; Carr A; Kelleher AD; Dore GJ; Matthews G; Brink R; Bull RA; Suan D; Goodnow CC, 2025, 'A triad of somatic mutagenesis converges in self-reactive B cells to cause a virus-induced autoimmune disease', Immunity, 58, pp. 412 - 430.e10, http://dx.doi.org/10.1016/j.immuni.2024.12.011

Nyein PP; Petoumenos K; Borok M; Eriobu N; Kumarasamy N; Avihingsanon A; Azwa I; Dao S; Cisse M; Dharan NJ; Hanson J; Matthews GV, 2025, 'Associations Between Antiretroviral Regimen and Changes in Blood Pressure: Results From the D2EFT Study', Clinical Infectious Diseases, 80, pp. 160 - 163, http://dx.doi.org/10.1093/cid/ciae256

Harney BL; Sacks-Davis R; van Santen DK; Stewart AC; Matthews GV; Carson JM; Klein MB; Lacombe K; Wittkop L; Salmon D; Leleux O; Merchadou L; van der Valk M; Smit C; Prins M; Boyd A; Berenguer J; Jarrin I; Rauch A; Hellard ME; Doyle JS, 2025, 'Unsuccessful Direct Acting Antiviral Hepatitis C Treatment Among People With HIV: Findings From an International Cohort', Liver International, 45, pp. 1 - 13, http://dx.doi.org/10.1111/liv.16203

Han WM; Sazzad HMS; Bloch M; Baker DA; Roth N; Bowden-Reid E; Smith DE; Hoy JF; Woolley I; Finlayson R; Templeton DJ; Matthews GV; Costello J; Dawson MA; Dawson SJ; Polizzotto MN; Petoumenos K; Yeh P; Dharan NJ; Winter D; Baker D; Lau H; Acklom K; Price S; O'Bryan J; Sinclair B, 2024, 'Age-related clonal hematopoiesis and HIV infection are associated with geriatric outcomes: The ARCHIVE study', Cell Reports Medicine, 5, http://dx.doi.org/10.1016/j.xcrm.2024.101835

Lau DTY; Jackson K; Picchio CA; Kramvis A; Sonderup M; Lemoine M; Matthews G; Howell J; Coffin CS; Hellard M; Lee AU; Anderson DA; Kerth HA; Lee EE; Tavis JE; Dandri M; Revill PA; Spearman CW; Penicaud C; Levrero M; El-Sayed M, 2024, 'Availability of point-of-care HBV tests in resource-limited settings', Lancet Gastroenterology and Hepatology, 9, pp. 1073 - 1076, http://dx.doi.org/10.1016/S2468-1253(24)00308-X

Martinello M; Carson JM; Post JJ; Finlayson R; Baker D; Read P; Shaw D; Bloch M; Doyle J; Hellard M; Filep E; Hosseini-Hooshyar S; Dore GJ; Matthews GV, 2024, 'Control and Elimination of Hepatitis C Virus Among People With HIV in Australia: Extended Follow-up of the CEASE Cohort (2014-2023)', Open Forum Infectious Diseases, 11, http://dx.doi.org/10.1093/ofid/ofae665

Akerman A; Fichter C; Milogiannakis V; Esneau C; Silva MR; Ison T; Lopez JA; Naing Z; Caguicla J; Amatayakul-Chantler S; Roth N; Manni S; Hauser T; Barnes T; Boss T; Condylios A; Yeang M; Sato K; Bartlett NN; Darley D; Matthews G; Stark DJ; Promsri S; Rawlinson WD; Murrell B; Kelleher AD; Dwyer D; Sintchenko V; Kok J; Ellis S; Marris K; Knight E; Hoad VC; Irving DO; Gosbell I; Brilot F; Wood J; Aggarwal A; Turville SG, 2024, 'Cross-sectional and longitudinal genotype to phenotype surveillance of SARS-CoV-2 variants over the first four years of the COVID-19 pandemic', Ebiomedicine, 110, http://dx.doi.org/10.1016/j.ebiom.2024.105415

Phetsouphanh C; Jacka B; Ballouz S; Jackson KJL; Wilson DB; Manandhar B; Klemm V; Tan HX; Wheatley A; Aggarwal A; Akerman A; Milogiannakis V; Starr M; Cunningham P; Turville SG; Kent SJ; Byrne A; Brew BJ; Darley DR; Dore GJ; Kelleher AD; Matthews GV, 2024, 'Improvement of immune dysregulation in individuals with long COVID at 24-months following SARS-CoV-2 infection', Nature Communications, 15, http://dx.doi.org/10.1038/s41467-024-47720-8

Hume SJ; Wong DK; Yuen MF; Jackson K; Bonanzinga S; Vogrin S; Hall SAL; Burns GS; Desmond PV; Sundararajan V; Ratnam D; Levy MT; Lubel JS; Nicoll AJ; Strasser SI; Sievert W; Ngu MC; Sinclair M; Meredith C; Matthews G; Revill PA; Littlejohn M; Bowden S; Visvanathan K; Holmes JA; Thompson AJ, 2024, 'High end-of-treatment hepatitis B core-related antigen levels predict hepatitis flare after stopping nucleot(s)ide analogue therapy', Liver International, 44, pp. 2605 - 2614, http://dx.doi.org/10.1111/liv.16029

Tillakeratne S; Pearson SA; Alavi M; Hajarizadeh B; Martinello M; Law M; George J; Amin J; Matthews G; Grebely J; Dore GJ; Valerio H, 2024, 'Trends in viral hepatitis liver-related morbidity and mortality in New South Wales, Australia', Lancet Regional Health Western Pacific, 51, http://dx.doi.org/10.1016/j.lanwpc.2024.101185

Martinello M; Matthews GV, 2024, 'Reinfection after Hepatitis C Virus Treatment - Keep Testing, Keep Treating', JAMA Network Open, 7, pp. e2430290, http://dx.doi.org/10.1001/jamanetworkopen.2024.30290

Dodd S; Mohebbi M; O'Donohue J; Matthews G; Darley DR; Berk M, 2024, 'Psychiatric sequelae after SARS-Cov-2 infection: Trajectory, predictors and associations in a longitudinal Australian cohort', Acta Neuropsychiatrica, 36, pp. 195 - 210, http://dx.doi.org/10.1017/neu.2023.45

Harney BL; Sacks-Davis R; Traeger M; van Santen DK; Wilkinson AL; Asselin J; Fairley CK; Roth N; Bloch M; Matthews G; Donovan B; Guy R; Hellard ME; Doyle JS, 2024, 'Annual hepatitis C testing and positive tests among gay and bisexual men in Australia from 2016 to 2022: a serial cross-sectional analysis of sentinel surveillance data', Sexually Transmitted Infections, 100, pp. 295 - 301, http://dx.doi.org/10.1136/sextrans-2024-056175

Marchal A; Cirulli ET; Neveux I; Bellos E; Thwaites RS; Schiabor Barrett KM; Zhang Y; Nemes-Bokun I; Kalinova M; Catchpole A; Tangye SG; Spaan AN; Lack JB; Ghosn J; Burdet C; Gorochov G; Tubach F; Hausfater P; Abel L; Aiuti A; Al-Muhsen S; Al-Mulla F; Amara A; Anderson MS; Andreakos E; Arias AA; Arkin LM; Feldman HB; Bastard P; Belot A; Biggs CM; Bogunovic D; Bolze A; Bondarenko A; Borghesi A; Bousfiha AA; Brodin P; Bryceson Y; Butte MJ; Casanova JL; Casari G; Christodoulou J; Cobat A; Colobran R; Condino-Neto A; Constantinescu SN; Cooper MA; Dalgard CL; Desai M; Drolet BA; Duval X; El Baghdadi J; Eloy P; Espinosa-Padilla S; Fellay J; Flores C; Franco JL; Froidure A; Gregersen PK; Grimbacher B; Haerynck F; Hagin D; Halwani R; Hammarström L; Heath JR; Hsieh EWY; Husebye E; Imai K; Itan Y; Jouanguy E; Kaja E; Karamitros T; Kisand K; Ku CL; Lau YL; Ling Y; Lucas CL; Maniatis T; Mansouri D; Maródi L; Mentré F; Meyts I; Milner JD; Mironska K; Mogensen TH; Morio T; Ng LFP; Notarangelo LD; Novelli A; Novelli G; O'Farrelly C; Okada S; Okamoto K; Özçelik T; Pan-Hammarström Q; Pape JW; Perez de Diego R; Perez-Tur J; Perlin DS; Pesole G, 2024, 'Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection', Human Genetics and Genomics Advances, 5, http://dx.doi.org/10.1016/j.xhgg.2024.100300

Matthews G; Jacoby S; Borok M; Eriobu N; Kaplan R; Kumarasamy N; Bennet JA; Avihingsanon A; Chetchotisakd P; Wagner Cardoso S; Azwa I; Losso M; Brown D; Arlinda D; Hutchinson J; Kelleher A; Cisse M; Dao S; Polizzotto M; Emery S; Law M; Papot E; Karyana M; Lupo S; Solari AM; Grinsztejn B; Wolff M; Andrade-Villanueva J; Mosqueda Gómez JL; Chow TS; Mohapi L; Yunihastuti E; Hadi U; Katu S; Subronto YW; Lane HC; Perelis L, 2024, 'Dolutegravir plus boosted darunavir versus recommended standard-of-care antiretroviral regimens in people with HIV-1 for whom recommended first-line non-nucleoside reverse transcriptase inhibitor therapy has failed (D2EFT): an open-label, randomised, phase 3b/4 trial', Lancet HIV, 11, pp. e436 - e448, http://dx.doi.org/10.1016/S2352-3018(24)00089-4

Valerio H; Alavi M; Marshall AD; Hajarizadeh B; Amin J; Law M; Tillakeratne S; George J; Degenhardt L; Grebely J; Matthews GV; Dore GJ, 2024, 'Factors associated with hepatitis C treatment uptake among females of childbearing age in New South Wales, Australia: A population-based study', Drug and Alcohol Review, 43, pp. 1080 - 1092, http://dx.doi.org/10.1111/dar.13688

Stewardson AJ; Davis JS; Dunlop AJ; Tong SYC; Matthews GV, 2024, 'How I manage severe bacterial infections in people who inject drugs', Clinical Microbiology and Infection, 30, pp. 877 - 882, http://dx.doi.org/10.1016/j.cmi.2024.01.022

Marshall AD; Willing AR; Kairouz A; Cunningham EB; Wheeler A; O'Brien N; Perera V; Ward JW; Hiebert L; Degenhardt L; Hajarizadeh B; Colledge S; Hickman M; Jawad D; Lazarus JV; Matthews GV; Scheibe A; Vickerman P; Dore GJ; Grebely J; Sargsyants N; Suleymanova L; Salkic N; Simonova M; Nemeth-Blazic T; Mravcik V; Kivimets K; Salupere R; Butsashvili M; Soselia G; Makara M; Tolmane I; Jancorienė L; Stratulat S; Flisiak R; Gheorghe L; Cernat R; Lakhov A; Stanevich O; Jarcuska P; Peck-Radosavljevic M; Robaeys G; Øvrehus A; Foster G; Sutinen J; Farkkila M; Rautiainen H; Vuoti S; Nikolova D; Pawlotsky JM; Rockstroh J; Sypsa V; Papatheodoridis G; Olafsson S; Feeney E; Teti E; Seguin-Devaux C; Pocock J; Reiff S; McDougall N; Van der Valk M; Dalgard O; Tato Marinho R; Dillon J; Peters E; Bojovic K; Matičič M; Kåberg M; Bruggmann P; Healy B; Chong VH; Yi S; Tucker J; Pasaribu LR; Tanaka J; Ashley EA; Abu Hassan MR; Mohammed NS; Chan HK; Gidaagaya S; Kyi KP; Hyung Joon K; Chin B; Baladjay PC; Kao JH; Wansom T; da Cruz B; Flower B; Ehsan E; Al Mahtab M; Khandu L; Bhadoria AS; Alavi M; KC P; Hamid S; Biryukov S; Alymbaeva D; Alaei A; Bakieva S; Flichman D, 2024, 'Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions', Lancet Gastroenterology and Hepatology, 9, pp. 366 - 382, http://dx.doi.org/10.1016/S2468-1253(23)00335-7

Harney BL; Sacks-Davis R; van Santen DK; Traeger MW; Wilkinson AL; Asselin J; Fairley CK; Roth N; Bloch M; Matthews GV; Donovan B; Guy R; Stoové M; Hellard ME; Doyle JS, 2024, 'Hepatitis C virus reinfection incidence among gay and bisexual men with HIV in Australia from 2016 to 2020', Liver International, 44, pp. 1024 - 1031, http://dx.doi.org/10.1111/liv.15841

Singh KP; Avihingsanon A; Zerbato JM; Zhao W; Braat S; Tennakoon S; Rhodes A; Matthews GV; Fairley CK; Sasadeusz J; Crane M; Audsley J; Lewin SR, 2024, 'Predictors of liver disease progression in people living with HIV-HBV co-infection on antiretroviral therapy', Ebiomedicine, 102, http://dx.doi.org/10.1016/j.ebiom.2024.105054

Harney BL; Sacks-Davis R; Agius P; van Santen DK; Traeger MW; Wilkinson AL; Asselin J; Fairley CK; Roth N; Bloch M; Matthews GV; Donovan B; Guy R; Stoové M; Hellard ME; Doyle JS; Aung HL; Baillie G; Bastian L; Bateson D; Boyd M; Carter A; Cogle A; Costello J; Dimech W; El-Hayek C; Ellard J; Franklin L; Hocking J; Kim J; Nguyen L; Nguyen T; Nolan D; O’Connor C; Patel P; Pendle S; Polkinghorne V; Reed P; Ryder N; Selvey C; Walker M; Watson N, 2024, 'Risk of Primary Incident Hepatitis C Infection Following Bacterial Sexually Transmissible Infections Among Gay and Bisexual Men in Australia From 2016 to 2020', Open Forum Infectious Diseases, 11, http://dx.doi.org/10.1093/ofid/ofae099

Bin Usman Shah SH; Alavi M; Hajarizadeh B; Matthews GV; Martinello M; Danta M; Amin J; Law MG; George J; Valerio H; Dore GJ, 2024, 'Corrigendum to “Trends in decompensated cirrhosis and hepatocellular carcinoma among people with a hepatitis B notification in New South Wales” [JHEP Reports 4 (2022)] (JHEP Reports (2022) 4(10), (S2589555922001240), (10.1016/j.jhepr.2022.100552))', Jhep Reports, 6, http://dx.doi.org/10.1016/j.jhepr.2024.101022

Sacks-Davis R; van Santen DK; Boyd A; Young J; Stewart A; Doyle JS; Rauch A; Mugglin C; Klein M; van der Valk M; Smit C; Jarrin I; Berenguer J; Lacombe K; Requena MB; Wittkop L; Leleux O; Bonnet F; Salmon D; Matthews GV; Guy R; Martin NK; Spelman T; Prins M; Stoove M; Hellard M; Ke T; Zhang Y; Pedrana A; Asselin J; Dawe J; Wilkinson A; Schinkel J; Sogni P; Esterle L; Gilbert C; Merchadou L; Gillet S; Khan C; Le Marec F; Perrier A; Shaw I; Martinello M; Applegate T; Carson J; Harney B; Bryant M; Jarrin Vera I; Alejos B; Lazarus JV; Moreno C; Izquierdo R; Rava M; Wang S; Lumia J; Pexos C; Peiris H; Saeed S; Moodie E; Pick N; Conway B; Hull M; Wong A; Gill J; Barrett L; Cohen J; Cox J; Cote P; Haider S; Rouleau D; Vachon ML; Rachlis A; Sandre R; Walmsley S; Sadr A; Cooper C; Sanche S; Salazar-Viscaya L; Kusejko K; Hage K; Requena MB; Girard PM; Brucker M; Vincensini JP, 2024, 'Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010–19: an analysis of data from a consortium of prospective cohort studies', Lancet HIV, 11, pp. e106 - e116, http://dx.doi.org/10.1016/S2352-3018(23)00267-9

van Santen DK; Stewart A; Doyle JS; Stoové MA; Asselin J; Klein MB; Young J; Berenguer J; Jarrin I; Lacombe K; Wittkop L; Leleux O; Salmon D; Bonnet F; Rauch A; Mugglin C; Matthews G; Prins M; Smit C; Boyd A; van der Valk M; Sacks-Davis R; Hellard ME, 2024, 'Cohort Profile: International Collaboration on Hepatitis C Elimination in HIV Cohorts (InCHEHC)', International Journal of Epidemiology, 53, http://dx.doi.org/10.1093/ije/dyad154

Shah SHBU; Valerio H; Hajarizadeh B; Matthews G; Alavi M; Dore GJ, 2023, 'Cascade of care among people with hepatitis B in New South Wales, Australia', Journal of Viral Hepatitis, 30, pp. 926 - 938, http://dx.doi.org/10.1111/jvh.13881

Matuozzo D; Talouarn E; Marchal A; Zhang P; Manry J; Seeleuthner Y; Zhang Y; Bolze A; Chaldebas M; Milisavljevic B; Gervais A; Bastard P; Asano T; Bizien L; Barzaghi F; Abolhassani H; Abou Tayoun A; Aiuti A; Alavi Darazam I; Allende LM; Alonso-Arias R; Arias AA; Aytekin G; Bergman P; Bondesan S; Bryceson YT; Bustos IG; Cabrera-Marante O; Carcel S; Carrera P; Casari G; Chaïbi K; Colobran R; Condino-Neto A; Covill LE; Delmonte OM; El Zein L; Flores C; Gregersen PK; Gut M; Haerynck F; Halwani R; Hancerli S; Hammarström L; Hatipoğlu N; Karbuz A; Keles S; Kyheng C; Leon-Lopez R; Franco JL; Mansouri D; Martinez-Picado J; Metin Akcan O; Migeotte I; Morange PE; Morelle G; Martin-Nalda A; Novelli G; Novelli A; Palabiyik F; Pan-Hammarström Q; de Diego RP; Planas-Serra L; Pleguezuelo DE; Prando C; Pujol A; Reyes LF; Rivière JG; Rodriguez-Gallego C; Rojas J; Rovere-Querini P; Schlüter A; Shahrooei M; Sobh A; Soler-Palacin P; Tandjaoui-Lambiotte Y; Tipu I; Tresoldi C; Troya J; van de Beek D; Zatz M; Zawadzki P; Al-Muhsen SZ; Alosaimi MF; Alsohime FM; Baris-Feldman H; Butte MJ; Constantinescu SN; Cooper MA; Dalgard CL; Fellay J; Heath JR; Lau YL; Lifton RP; Maniatis T; Mogensen TH; von Bernuth H; Lermine A; Vidaud M; Boland A, 2023, 'Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19', Genome Medicine, 15, http://dx.doi.org/10.1186/s13073-023-01173-8

Smith MZ; Turner M; Haurat J; Thevarajan I; Denholm J; Tong SY; Matthews GV; Bull RA; Martinello M; McMahon J; Imrie A; Pillai PE, 2023, 'The APPRISE Virtual Biobank for Infectious Diseases', Communicable Diseases Intelligence 2018, 47, http://dx.doi.org/10.33321/cdi.2023.47.66

Dharan NJ; Sasson SC; Ahlenstiel G; Andersen CR; Bloch M; Buckland G; Hamad N; Han WM; Kelleher AD; Long GV; Matthews GV; Mina MM; Papot E; Petoumenos K; Swaminathan S; Withers B; Yun J; Polizzotto MN, 2023, 'Clinical and laboratory features of COVID-19 illness and outcomes in immunocompromised individuals during the first pandemic wave in Sydney, Australia', Plos One, 18, http://dx.doi.org/10.1371/journal.pone.0289907

Back to profile page